Valuation: Grand Pharmaceutical Group Limited

Market Cap 1.51TCr 192.8Cr 172.69Cr 159.32Cr 144.17Cr 269.6Cr 18TCr 273.95Cr 1.9TCr 758.29Cr 9.61TCr 723.57Cr 708.16Cr 30TCr P/E 2026 *
8.39x
P/E 2027 * 7.68x
Enterprise Value 1.51TCr 192.8Cr 172.69Cr 159.32Cr 144.17Cr 269.6Cr 18TCr 273.95Cr 1.9TCr 758.29Cr 9.61TCr 723.57Cr 708.16Cr 30TCr EV / Sales 2026 *
1.17x
EV / Sales 2027 * 1.07x
Free-Float
34.99%
Yield 2026 *
4.86%
Yield 2027 * 5.32%
1 day-0.58%
1 week-5.57%
Current month-12.37%
1 month-10.74%
3 months-15.62%
6 months-31.75%
Current year-44.97%
1 week 4.3
Extreme 4.3
4.54
1 month 4.3
Extreme 4.3
4.96
Current year 4.3
Extreme 4.3
8.18
1 year 4.3
Extreme 4.3
8.88
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 01/06/2021
Corporate Secretary 57 01/09/2011
Director TitleAgeSince
Director/Board Member 63 21/03/2005
Director/Board Member 66 12/05/2011
Director/Board Member 62 31/12/2018
Date Insider Type Main position Quantity % Market Cap. Importance
07/09/26 Other

Chief Executive Officer

21,500 0.0006%
22/04/26 Other

Chairman

50,000 0.0014%
21/04/26 Other

Chief Executive Officer

58,500 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%-5.57%-46.86%+5.37% 193.94Cr
+6.63%+8.10%+67.50%+145.20% 1,14800Cr
+1.53%+6.76%+47.22%+89.01% 65TCr
+1.68%+2.10%+27.80%+109.31% 51TCr
+0.73%+2.47%+53.85%+68.96% 38TCr
+3.83%-2.37%+68.14%+42.32% 35TCr
+2.38%+4.27%+33.81%+57.95% 29TCr
+2.26%+3.47%+5.21%+28.92% 26TCr
+1.97%+5.11%+57.74%+76.14% 24TCr
+4.03%+7.84%+40.49%+116.14% 20TCr
Average +2.05%+0.74%+35.49%+73.93% 40.39TCr
Weighted average by Cap. +2.25%+1.50%+49.53%+95.93%

Financials

2026 *2027 *
Net sales 1.29TCr 164.96Cr 147.76Cr 136.32Cr 123.36Cr 230.67Cr 16TCr 234.4Cr 1.63TCr 648.8Cr 8.22TCr 619.09Cr 605.91Cr 26TCr 1.41TCr 179.73Cr 160.98Cr 148.52Cr 134.4Cr 251.31Cr 17TCr 255.38Cr 1.77TCr 706.87Cr 8.96TCr 674.5Cr 660.14Cr 28TCr
Net income 182.65Cr 23Cr 21Cr 19Cr 17Cr 33Cr 2.22TCr 33Cr 229.49Cr 92Cr 1.16TCr 87Cr 86Cr 3.67TCr 199.1Cr 25Cr 23Cr 21Cr 19Cr 35Cr 2.42TCr 36Cr 250.16Cr 100Cr 1.26TCr 95Cr 93Cr 4.01TCr
Net Debt - -
Projected Income Statement - Annual - Grand Pharmaceutical Group Limited
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,326
Date Price Change Volume
29/26/29 HK$4.320 -0.58% 35,97,000
28/26/28 HK$4.345 -0.80% 31,95,210
27/26/27 HK$4.380 -1.13% 38,79,500
26/26/26 HK$4.430 -0.56% 31,82,000
23/26/23 HK$4.455 +1.14% 18,09,000
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Grand Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.320HKD
Average target price
9.527HKD
Spread / Average Target
+120.52%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Grand Pharmaceutical Group Limited